A Clinical Study of 265 Patients with Vitiligo in the Gwangju Chonnam Province

광주 전남지방에 거주하는 백반증 환자 265 예에 대한 임상적 고찰

Ki, Ho-Gyun;Yun, Sook-Jung;Lee, Jee-Bum;Kim, Seong-Jin;Won, Young-Ho;Lee, Seung-Chul
기호균;윤숙정;이지범;김성진;원영호;이승철

  • Published : 20051000

Abstract

Keywords

References

  1. Ortonne JP, Mosher DB, Fitzpatrick TB: Hypomelanotic disorders: Vitiligo and other hypomelanoses of hair and skin. Plenum, New York, 1983:120-310
  2. Ortonne JP, Bahadoran P, Fitzpatrick TB, Mosher DB, Hori Y. Hypomelanoses and hypermelanoses, In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editors. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hili, 2003: 836-862
  3. Hann SK. Historical and social considerations of vitiligo. Update in Dermatology. 2004;2(1);6-8
  4. Boissy RE, Liu YY, Medrano EE, Nordlund JJ. Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients. J Invest Dermatol 1991;97:395-404 https://doi.org/10.1111/1523-1747.ep12480976
  5. Maresca V, Roccella M, Roccella F, Camera E, Del Porto G, Passi S, et al. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol 1997;109:310-313 https://doi.org/10.1111/1523-1747.ep12335801
  6. Badri AM, Todd PM, Garioch JJ, Gudgeon JE, Stewart DG, Gracie RB. An immunohistological study of cutaneous lymphocytes in vitiligo, J Pathol 1993;170:149-155 https://doi.org/10.1002/path.1711700209
  7. al Badri AM, Foulis AK, Todd PM, Gariouch JJ, Gudgeon JE, Stewart DG et al. Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo. J pathol 1993;169:203-206 https://doi.org/10.1002/path.1711690205
  8. Naughton GK, Eisinger M, Bystryn JC. Detection of antibodies to melanocytes in vitiligo. J Invest Dermatol 1983;81(6):540-542 https://doi.org/10.1111/1523-1747.ep12522891
  9. Yu HJ, Park KC. Ahn JS, Lim JG, Kwon TE, Koh WS, et al. Clinical study of vitiligo. Korean J Dermatol 1998;36:1037-1042
  10. Cho SY, Kang He. Classification of vitiligo based on its clinical types. Korean J Dermatol 1997;35:627-637
  11. Lerner AB. Vitiligo, J Invest Dermatol 1959;32:285-310 https://doi.org/10.1038/jid.1959.49
  12. Ryoo YW, Jung JB, Choi YE, Rho YJ, Lee KS, Song JY, A clinical study of 225 patients with generalized vitiligo, Korean J Dermatol 1993;31:664-671
  13. Park SY, Youn Jl, Lim SD, A clinical study of 217 cases of vitiligo. Korean J Dermatol 1981;19:171-182
  14. Park KC, Youn Jl, Lee YS. Clinical study of 326 cases of vitiligo. Korean J Dermatol 1988;26:200-205
  15. Song MS, Harm SK, Ahn PS, Im SB, Park YK. Clinical study of vitiligo, Ann Dermatol 1994;6:22-30
  16. Fitzpatrick TB. Hypomelanosis. South Med J 1964;57:995-1005 https://doi.org/10.1097/00007611-196409000-00001
  17. Mehta NR. Epidemiological study of vitiligo in Surat area, South Gujarat. Indian J Med Res 1973;61:145-157
  18. Hann SK, Lee HS, Park YK. Clinical features of vitiligo. Ann Dermatol 1998;10:217-228
  19. Seghal VN. A clinical evaluation of 202 cases of vitiligo, Cutis 1974;14:439-448